WT1 Vaccine Helped High-Risk Multiple Myeloma Patients After Stem Cell Transplant
High-risk multiple myeloma patients may benefit markedly from galinpepimut-S,…
Myeloma
Myeloma overview
Myeloma is a rare blood cancer that begins in plasma cells, a type of white blood cell normally responsible for producing antibodies that help fight off infectious pathogens and other threats.
Read moreMyeloma treatment
While myeloma treatment can drive the disease into remission, sometimes for long periods of time, the cancer will often come back after a few months or years, and additional treatments will be needed.
Read moreLatest news
UV Light Robots Reduced Hospital-Acquired Infections by 25%, Study Finds
Robots can do all sorts of tasks to improve…
FDA Grants Priority Review to Darzalex Combo Therapy for Relapsed Multiple Myeloma Patients
The U.S. Food and Drug Administration (FDA) is…
Study Furthers Knowledge of How Multiple Myeloma Cells Take Hold in Bone Marrow
The communication between multiple myeloma cells and healthy bone…
MMRF Opening Wealth of Myeloma Genomic Data to Researchers via NCI
The Multiple Myeloma Research Foundation (MMRF) is going…
Kyprolis Combo Fails to Outperform Velcade for Multiple Myeloma Patients Newly Diagnosed
Treatment of newly diagnosed multiple myeloma patients with a combination…
